Intrathecal administration of yohimbine impairs locomotion in intact rats.
The effects of upper lumbar level intrathecal injection of yohimbine, an alpha2-noradrenergic antagonist, on overground locomotion in intact rats was studied. This treatment caused dose-dependent impairment of hindlimb locomotor movement, which varied from transient hindlimb paralysis at a dose of 200 microg/20 microl to transient trunk instability at 50 microg/20 microl. Repetitive (every 48 h) injections of yohimbine at high (200 microg/20 microl) and medium (100 microg/20 microl) doses caused tachyphylaxis, which usually led to a lack of reaction to the third injection. This phenomenon was not observed after repetitive injections of the low (50 microg/20 microl) dose of the drug. These results show that the noradrenergic system is involved in the control of locomotion, since intrathecal administration of a specific antagonist affects this activity in intact rats.